Hox基因
神经外胚层
软骨
细胞生物学
透明软骨
生物
中胚层
间充质干细胞
再生(生物学)
胚胎干细胞
免疫学
病理
解剖
医学
遗传学
转录因子
骨关节炎
基因
关节软骨
替代医学
作者
Karoliina Pelttari,Benjamin E. Pippenger,Marcus Mumme,Sandra Feliciano,Celeste Scotti,Pierre Mainil‐Varlet,Alfredo Procino,Brigitte von Rechenberg,Thomas Schwamborn,Marcel Jakob,Clemente Cillo,Andrea Barbero,Ivan Martin
出处
期刊:Science Translational Medicine
[American Association for the Advancement of Science (AAAS)]
日期:2014-08-27
卷期号:6 (251)
被引量:94
标识
DOI:10.1126/scitranslmed.3009688
摘要
In embryonic models and stem cell systems, mesenchymal cells derived from the neuroectoderm can be distinguished from mesoderm-derived cells by their Hox-negative profile--a phenotype associated with enhanced capacity of tissue regeneration. We investigated whether developmental origin and Hox negativity correlated with self-renewal and environmental plasticity also in differentiated cells from adults. Using hyaline cartilage as a model, we showed that adult human neuroectoderm-derived nasal chondrocytes (NCs) can be constitutively distinguished from mesoderm-derived articular chondrocytes (ACs) by lack of expression of specific HOX genes, including HOXC4 and HOXD8. In contrast to ACs, serially cloned NCs could be continuously reverted from differentiated to dedifferentiated states, conserving the ability to form cartilage tissue in vitro and in vivo. NCs could also be reprogrammed to stably express Hox genes typical of ACs upon implantation into goat articular cartilage defects, directly contributing to cartilage repair. Our findings identify previously unrecognized regenerative properties of HOX-negative differentiated neuroectoderm cells in adults, implying a role for NCs in the unmet clinical challenge of articular cartilage repair. An ongoing phase 1 clinical trial preliminarily indicated the safety and feasibility of autologous NC-based engineered tissues for the treatment of traumatic articular cartilage lesions.
科研通智能强力驱动
Strongly Powered by AbleSci AI